PET/CT in staging and treatment evaluation of non-small cell lung cancer
DOI:
https://doi.org/10.37711/rpcs.2022.4.3.378Keywords:
non-small cell lung cancer, PET/CT, treatment, noninvasive surgery, radiomics, computed tomographyAbstract
Lung cancer is a health problem in Peru, being the most aggressive in its behavior. It affects men and women equally. PET/CT is a useful tool in the staging and follow-up of the treatment of these tumors. At present, there is enough evidence to afrm that this technology allows to adjust the treatment and to have an influence on long term survival. In this work we have made a descriptive review of the relevant articles recently published on the subject. It is concluded that the PET/CT study is useful in the staging and follow-up of the proposed treatment for patients with non-small cell lung cancer. We also have the information that this malignant tumor continues to arrive at medical consultations at an advanced stage.
Downloads
References
Fischer B, Lassen U, Mortensen J, Larsen S, Loft A, Bertelsen A et al. Preoperative Staging of Lung Cancer with Combined PET–CT. The New England Journal of Medicine. 2009; 361: 32-9.
Farsad M. FDG PET/CT in the staging of Lung Cancer. Current Radiopharmaceuticals. 2020; 13: 195-203.
The Global Cancer Observatory. GloboCan [Internet] [Consultado 2022 Sep 19]. Disponible en: https://gco.iarc.fr/today/data/factsheets/cancers/15-Lung-factsheet.pdf
Instituto Nacional de Enfermedades Neoplásicas. Dirección de Control del Cáncer. Manual en Salud. Prevención de Cáncer. Lima: WEYA Comunicación y Marketing; 2019.
Lima N, Cancela M, Becerra D. Spatial assessment of advanced-stage diagnosis and lung cancer mortality in Brazil. Plos One 2022; [Internet]. 2022 [Consultado 2022 Sep 19]; 17(3): e0265321. https://doi.org/10.1371/journal.pone.0265321
Mu W, Jiang L, Zhang J, Shi Y, Gray J, Tunali I, et al. Noninvasive decision support for NSCLC treatment using PET/CT radiomics. Nature Communications [Internet]. 2020 [Consultado 2022 Sep 19]; 11: 5228. https://doi.org/10.1038/s41467-020-19116-x | www.nature.com/naturecommunications
Maurer M, Kasmann L, Fleischmann D, Oertel M, Jazmati D, Medenwald D, et al. PET/CT-based adaptive radiotherapy of locally advanced non-small cell lung cancer in multicenter y DEGRO ARO 2017-01 cohort Study. Radiation Oncology [Internet].2022 [Consultado 2022 Sep 19]; 17(29). doi: https://doi.org/10.1186/s13014-022-01997-5
Han Y, Ma Y, Wu Z, Zhang F, Zheng D, Liu X, et al. Histologic subtype classifcation of non-small cell lung cancer using PET/CT images. European Journal of Nuclear Medicine and Molecular Imaging [Internet]. 2020 [Consultado 2022 Sep 19]. doi: https://doi.org/10.1007/s00259-020-04771-5
Popat S, Navani N, Smit E, Batchelor T, Van Schil P, Senan S, et al. Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach. The Oncologist. [Internet]. 2021 [Consultado 2022 Sep 19]; 26: e306–e315. Disponible en: https://academic.oup.com/oncolo/article/26/2/e306/6445376
Chen L, Sun H, Huang Y. PET-CT Principles and Applications in Lung Cancer Management. [Internet] 2019 [Consultado 2022 Sep 19]. doi: http://dx.doi.org/10.5772/intechopen.8871
Kaseda K. Recent and Current Advances in FDG-PET Imaging within the Field of Clinical Oncology in NSCLC: A Review of the Literature. Diagnostics [Internet]. 2020
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Christian Martel-Carranza
This work is licensed under a Creative Commons Attribution 4.0 International License.
